Celltrion Clinical Trials

Clinical trials sponsored by Celltrion — phases, conditions and reported results. Data from ClinicalTrials.gov.

• Pembrolizumab in MarginalzoneLymphoma A MULTICENTER OPEN LABEL SINGLE-ARM PHASE II STUDY
  Phase 2 · Marginal Zone Lymphoma · Terminated · Feb 27, 2026
• To Compare Efficacy and Safety of CT-P39 and EU-approved Xolair in Patients With Chronic Spontaneous Urticaria
  Phase 3 · Chronic Spontaneous Urticaria · Completed · Jul 29, 2025
• To Compare Efficacy and Safety of CT-P16 and European Union-Approved Avastin as First-Line Treatment for Metas
  Phase 3 · Adenocarcinoma of Lung · Completed · Mar 17, 2025
• Demonstrate Efficacy and Safety of Metastatic Breast Cancer
  Phase 3 · Metastatic Breast Cancer · Completed · Feb 11, 2025
• Evaluate Safety, Efficacy and Pharmacokinetics
  Phase 1/2 · Metastatic Breast Cancer · Completed · Jan 24, 2025
• An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With Ankylosing Spondylitis
  N/A · Ankylosing Spondylitis · Terminated · Dec 9, 2024
• An Observational Study to Evaluate Safety and Efficacy of Remsima™ in Patients With RA
  N/A · Rheumatoid Arthritis · Terminated · Feb 5, 2024
• A Study to Compare Efficacy and Safety of CT-P47 and RoActemra in Patients With Rheumatoid Arthritis
  Phase 3 · Rheumatoid Arthritis · Completed · Oct 8, 2024
• A Phase 3 Study to Compare Between CT-P41 and US-licensed Prolia in Postmenopausal Women With Osteoporosis
  Phase 3 · Postmenopausal Women With Osteoporosis · Completed · May 16, 2024
• Study to Compare Efficacy and Safety of CT-P42 in Comparison With Eylea in Patients With Diabetic Macular Edem
  Phase 3 · Diabetic Macular Edema · Completed · Dec 5, 2023
• CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Crohn's Disease
  Phase 3 · Crohn's Disease · Completed · Oct 23, 2023
• CT-P13 (Infliximab) Subcutaneous Administration in Patients With Moderately to Severely Active Ulcerative Coli
  Phase 3 · Ulcerative Colitis · Completed · Sep 28, 2023
• A Study to Compare the Efficacy and Safety of CT-P43 to Stelara in Patients With Plaque Psoriasis
  Phase 3 · Psoriasis · Completed · Jun 5, 2023
• To Compare the PK and Safety of Omalizumab (CT-P39, EU-approved Xolair, and US-licensed Xolair) in Healthy Sub
  Phase 1 · Healthy · Completed · May 11, 2023
• A Study to Evaluate the Efficacy and Safety of CT-P27 in Acute Uncomplicated Influenza A Infection
  Phase 2 · Influenza A · Terminated · Oct 31, 2022

Trials by company

PfizerMerck (MSD)RocheNovartisAstraZenecaJohnson & Johnson (Janssen)Bristol Myers SquibbSanofiGSKEli LillyAbbVieAmgenBayerBoehringer IngelheimNovo NordiskTakedaGilead SciencesModernaBioNTechRegeneronVertexBiogenDaiichi SankyoAstellas PharmaEisaiOtsukaServierIncyteCelltrionSamsung BioepisHanmi PharmaceuticalYuhan

All trials